Oppenheimer Asset Management Inc. grew its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 15.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 65,075 shares of the company’s stock after purchasing an additional 8,695 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Option Care Health were worth $1,803,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Park Place Capital Corp boosted its holdings in Option Care Health by 48.4% during the first quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after buying an additional 372 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after acquiring an additional 377 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of Option Care Health by 130.2% in the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock worth $28,000 after acquiring an additional 478 shares during the period. Nisa Investment Advisors LLC increased its stake in Option Care Health by 5.4% in the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after purchasing an additional 690 shares in the last quarter. Finally, Principal Securities Inc. acquired a new position in Option Care Health during the fourth quarter worth $27,000. 98.05% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Option Care Health
In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the completion of the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now directly owns 21,339 shares of the company’s stock, valued at $663,429.51. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The disclosure for this sale can be found here. Insiders own 0.64% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Stock Report on OPCH
Option Care Health Stock Performance
NASDAQ OPCH opened at $31.11 on Thursday. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. Option Care Health, Inc. has a fifty-two week low of $26.11 and a fifty-two week high of $34.63. The business has a fifty day moving average of $31.10 and a 200-day moving average of $30.47. The stock has a market cap of $5.41 billion, a price-to-earnings ratio of 20.47, a price-to-earnings-growth ratio of 2.46 and a beta of 1.29.
Option Care Health (NASDAQ:OPCH – Get Free Report) last announced its earnings results on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The firm had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the previous year, the company posted $0.63 EPS. The firm’s revenue for the quarter was up 14.8% on a year-over-year basis. As a group, analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
- Five stocks we like better than Option Care Health
- Canadian Penny Stocks: Can They Make You Rich?
- How Much Can You Make in Stocks in One Month?
- Basic Materials Stocks Investing
- This Is the Top Large-Cap Stock Insiders Are Buying
- How to Use Stock Screeners to Find Stocks
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.